Dr Philippe Pouletty, MD – Co-Founder and General Partner, Life Sciences
Dr Philippe Pouletty: MD – Co-Founder and General Partner, Life Sciences
- Biotech industry veteran with a dual experience in Silicon Valley and in France
- Founder of three biotechnology companies: SangStat, Conjuchem, and DrugAbuse. Two of them have gone public: SangSat in 1993 (Nasdaq: SANG) later sold to Genzyme for $600 million and Conjuchem in 2000 (Toronto Stock Exchange: CJB)
- Chairman of France Biotech, the French Biotechnology Industry Association
- Former Vice-Chairman of Europabio, the European Biotech Industry Association
- Inventor of 29 patents
- Board member of BMD, Carmat, Cytomics, Deinove, Immune Targeting Systems (UK), Neovacs, Splicos, Symetis (Switzerland), Theraclion, Vexim, Wittycell
- Independent board member of Innate Pharma
- « Chevalier de la Légion d’Honneur »
- MD from University of Paris VI, immunology, laureate from Pasteur Institute. Post-doctoral research fellow at Stanford University and 1999 laureate of the American Liver Foundation
- Former member of the “Conseil Stratégique pour l’Attractivité de la France”, chaired by the French prime minister